Evidence map›Paper›PMID 42383350›Full record

ArticleThe Journal of clinical investigation2026

Mechanoreceptor plexin D1 regulates lymphatic valve morphogenesis and lymphedema pathogenesis.

Kar-Lai Pang, Vedanta Mehta, Claire Aitken, Sara E Dobbins, Jing Yu, Gabriele Bonetti, Adam N Keen, Feiran Zhang, Amélie Sabine, Tatiana V Petrova and 7 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kar-Lai PangDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.
Vedanta MehtaDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.
Claire AitkenDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.
Sara E DobbinsSchool of Health and Medical Sciences, City St George's University of London, London, United Kingdom.
Jing YuCentre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Gabriele BonettiMAGI Euregio, Bolzano, Italy.
Adam N KeenDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.
Feiran ZhangDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.
Amélie SabineDepartment of Oncology, University of Lausanne and Ludwig Institute for Cancer Research, Lausanne, Switzerland.
Tatiana V PetrovaDepartment of Oncology, University of Lausanne and Ludwig Institute for Cancer Research, Lausanne, Switzerland.
Paul R RileyDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.
E Yvonne JonesCentre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Sandro MicheliniDiagnostic and rehabilitative Service, San Giovanni Battista Hospital, Rome, Italy.
Matteo BertelliMAGI Euregio, Bolzano, Italy.
John S ReaderDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.
Pia OstergaardSchool of Health and Medical Sciences, City St George's University of London, London, United Kingdom.
Ellie TzimaDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphatic valves are essential for maintaining tissue fluid homeostasis, and their dysfunction leads to lymphedema, a morbid and disfiguring disease without a cure. Mechanical forces due to lymph flow are required for proper lymphatic valve development, yet it remains unclear how lymphatic endothelial cells (LECs) sense and decode mechanical signals. In this study, we identify the cell guidance semaphorin receptor plexin D1 (PLXND1) as a lymphatic mechanosensor required for lymphatic valve morphogenesis. Conditional genetic ablation of Plxnd1 in LECs caused major defects in lymphatic valve development in 2 different lymphatic vascular beds. Mechanistically, PLXND1 acted as a mechanosensor within a lymphatic mechanocomplex, initiating distinct mechanical signals and activating the lymphatic valve transcriptional program through an unconventional pathway. Screening of patients with primary lymphedema identified PLXND1 missense variants, and functional analysis established 2 pathogenic variants that selectively disrupt the ligand versus mechanosensing functions of this receptor. Variants associated with lymphedema in members of the mechanocomplex disrupted its formation, underscoring the central role of this complex in lymphatic valve biology. Our work uncovers a mechanosensing mechanism guiding lymphatic valve development, and has profound implications for the understanding and treatment of primary lymphedema in humans.

Indexed as

Intracellular Signaling Peptides and ProteinsLymphatic VesselsLymphedemaMechanotransduction, CellularMembrane GlycoproteinsAnimalsEndothelial CellsFemaleHumansLymphangiogenesisMaleMiceMice, TransgenicMutation, MissenseIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsPLXND1 protein, humanPlxnd1 protein, mouseCell biologyEndothelial cellsLymphVascular biology

Identifiers

PMID42383350
PMCPMC13318119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.